$XRN Cashflow Statement | Understand Stock

$XRN

$29.58 -$0.42 (1.4%) Close

$XRN Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Operating activities
Net income (loss)
Net (loss) income
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Depreciation expense
Amortization of acquired lease intangible assets
Amortization of above market leases, net
Amortization of debt issuance costs and other
Stock-based compensation expense
Capitalized preacquisition and other costs charged to expense
Noncash lease expense
Reserve for uncollectible accounts, net
Gain on sale of investment properties
Impairment of investment property
Equity loss from unconsolidated joint venture
Loss on extinguishment of debt
Other
Changes in operating assets and liabilities:
Tenant receivables
Deferred assets
Other assets and liabilities
Accounts payable and accrued expenses
Security deposits
Accrued management fees due to related party

Net cash provided by operating activities

Investing activities
Purchase of land, buildings, and other tangible and intangible assets and liabilities
Internalization - cash paid for acquisition of Former Advisor, net of cash acquired of $559
Net proceeds from sale of investment properties
Investment in unconsolidated joint venture
Distribution of capital from unconsolidated joint venture
Escrow deposits for purchase of properties
Advances received from (made to) related parties
Payment received on loan made to a tenant
Capital expenditures on existing real estate investments
Leasing commissions
Net cash (used in) provided by investing activities

Financing activities
Net proceeds received from common equity offerings
Proceeds from notes payable
Net proceeds received from preferred stock offering
Escrow deposits required by third party lenders
Repayment of notes payable
Repayment of CMBS loan defeasance
Proceeds from Credit Facility
Repayment of Credit Facility
Payment of debt issuance costs
Repurchase of common stock
Dividends paid to common stockholders, and OP Unit and LTIP Unit holders
Dividends paid to preferred stockholders
Net cash provided by financing activities

Net increase (decrease) in cash and cash equivalents and restricted cash
Cash and cash equivalents and restricted cash-beginning of period
Cash and cash equivalents and restricted cash-end of period
Supplemental cash flow information:
Cash payments for interest
Noncash financing and investing activities:
Accrued dividends payable
Interest rate swap agreements fair value change recognized in other comprehensive (loss) income
LTIP Units and OP Units redeemed for common stock
Accrued capital expenditures and leasing commissions included in accounts payable and accrued expenses
OP Units issued for property acquisitions
Loan assumed in connection with a facility acquisition
Accrued common stock offering costs
Recognition of lease liability related to right of use asset
Write off of unamortized debt issuance costs from loan defeasance

Comments